{
  "@type": "dcat:Dataset",
  "accessLevel": "public",
  "accrualPeriodicity": "R/P1Y",
  "bureauCode": [
    "009:10"
  ],
  "contactPoint": {
    "@type": "vcard:Contact",
    "fn": "Division of Drug Information",
    "hasEmail": "mailto:druginfo@fda.hhs.gov"
  },
  "description": "Olmesartan Medoxomil and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a diuretic to treat high blood pressure. Available as oral tablets in strengths like 12.5mg/20mg, 12.5mg/40mg, and 25mg/40mg, it's taken by mouth. This information was generated using AI and is provided for informational and research purposes only.",
  "distribution": [
    {
      "@type": "dcat:Distribution",
      "description": "\n        Access the FDA dataset for Olmesartan medoxomil and hydrochlorothiazide — ANDA 207804 submitted by Mylan Institutional LLC\n    ",
      "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207804",
      "mediaType": "text/html",
      "title": "Olmesartan medoxomil and hydrochlorothiazide"
    }
  ],
  "identifier": "ANDA207804",
  "issued": "2016-09-16",
  "keyword": [
    "drug-information",
    "drug-manufacturers",
    "fda",
    "health-care",
    "public-health"
  ],
  "landingPage": "https://www.fda.gov/drugs",
  "license": "https://open.fda.gov/license",
  "modified": "2025-03-17",
  "programCode": [
    "009:002"
  ],
  "publisher": {
    "@type": "org:Organization",
    "name": "U.S. Food and Drug Administration"
  },
  "theme": [
    "FDA"
  ],
  "title": "Olmesartan medoxomil and hydrochlorothiazide"
}